A Boston-based biopharmaceutical company is revolutionizing the weight-loss drug industry. Syntis Bio has created a daily ...

In an abrupt and surprising twist, the CEO of Ozempic-maker Novo Nordisk has been ousted from his position as the head of the ...

From marathon gym sessions and trendy detox teas to the latest GLP-1 injections, people will try just about anything to get ...

Pharmaceutical company Novo Nordisk, maker of blockbuster weight loss drug Wegovy, says its CEO is stepping down.

Lars Fruergaard Jorgensen, the chief executive of once-highflying Danish drugmaker Novo Nordisk, is stepping down after eight ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

While natural approaches to raising GLP-1 are not as potent as medications, they provide a drug-free approach to weight loss ...

Ozempic and Wegovy would no longer be covered by the state’s health insurance for low-income people under the governor’s ...

Jack in the Box JACK.O is seeking to offload its struggling Del Taco restaurant business and suspended its dividend as part of a restructuring plan under new CEO Lance Tucker. Shares of the ...

As the use of GLP-1s soars in popularity, diners are wrestling with new restaurant etiquette dilemmas — and adjusting ...